Evidence map›Paper›PMID 30811539›Full record

ArticleThe Journal of clinical endocrinology and metabolism2019

Truncating RAX Mutations: Anophthalmia, Hypopituitarism, Diabetes Insipidus, and Cleft Palate in Mice and Men.

Cécile Brachet, Elena A Kozhemyakina, Emese Boros, Claudine Heinrichs, Irina Balikova, Julie Soblet, Guillaume Smits, Catheline Vilain, Peter H Mathers

Abstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Novel homozygous mutation in the humanCase reports in perinatal medicine · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. "Orocrinology": Seven Easy Steps!Indian journal of endocrinology and metabolism
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cécile BrachetPediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Elena A KozhemyakinaDepartment of Biochemistry, West Virginia University School of Medicine, Morgantown, West Virginia.
Emese BorosPediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Claudine HeinrichsPediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Irina BalikovaPediatric Ophthalmology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Julie SobletDepartment of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Guillaume SmitsDepartment of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Catheline VilainDepartment of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium.
Peter H MathersDepartment of Biochemistry, West Virginia University School of Medicine, Morgantown, West Virginia.

Funding

Molecular control of retinal stem cell developmentR01EY012152 · NEI · WEST VIRGINIA UNIVERSITY · PI MATHERS, PETER H · 2005 to 2007
$968k
NEI NIH HHS R01 EY012152
6 · The paper itself

Abstract

contextThe transcription factor RAX is a paired-type homeoprotein that plays a critical role in eye and forebrain development of vertebrate species. RAX knockout mice have anophthalmia, cleft palate, and an abnormal hypothalamus and display perinatal lethality. In humans, homozygous or compound heterozygous RAX mutations have been reported to cause bilateral microphthalmia or anophthalmia without consistent associated features. Congenital hypopituitarism can be associated with various eye or craniofacial anomalies; however, the co-occurrence of congenital hypopituitarism, anophthalmia, cleft palate, and diabetes insipidus has been very rare.

resultsWe report the case of a child with anophthalmia, congenital hypopituitarism, diabetes insipidus, and bilateral cleft lip and palate who had a homozygous frameshift truncating mutation c.266delC (p.Pro89Argfs*114) in exon 1 of the RAX gene. Rax knockout mice show loss of ventral forebrain structures, pituitary, and basosphenoid bone and palate and a misplaced anterior pituitary gland along the roof of the oral cavity.

conclusionsOur patient's phenotype was more severe than that reported in other patients. Although most of the previously reported patients with RAX mutations showed either a missense or some less severe mutation in at least one of their RAX alleles, our patient was homozygous for truncating mutations that would yield a severe, null protein phenotype. The severity of the genetic defect, the precise match between the knockout mouse and the patient's endocrine phenotypes, and the prominent roles of RAX in eye and pituitary development and diencephalic patterning suggest that the RAX null mutations could fully account for the observed phenotype.

Indexed as

AnimalsAnophthalmosAntidiuretic AgentsCleft LipCleft PalateDeamino Arginine VasopressinDiabetes InsipidusEye ProteinsFrameshift MutationHomeodomain ProteinsHormone Replacement TherapyHuman Growth HormoneHumansHydrocortisoneHypopituitarismInfant, NewbornAntidiuretic AgentsDeamino Arginine VasopressinEye ProteinsHomeodomain ProteinsHuman Growth HormoneHydrocortisoneMelatoninRAX protein, humanRax protein, mouseThyroxineTranscription Factors

Identifiers

PMID30811539
PMCPMC6543774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.